Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A conventional osteosarcoma characterized by the presence of spindle shaped cells.
Biomarker and diagnostic research for fibrosarcomatous osteosarcoma has been reported in the published literature.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
104 publications have been identified in PubMed for fibrosarcomatous osteosarcoma. Research spans Basic Science / Preclinical (54%), Review / Meta-Analysis (13%), and Diagnostic / Biomarker (10%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 56 | 54% |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 6:53 PM UTC
Research summaries |
14 |
13% |
Testing and diagnosis research | 10 | 10% |
New treatment approaches | 10 | 10% |
Patient case studies | 8 | 8% |
Disease patterns and progression | 4 | 4% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Santos I (2026). [PMID: 41901344](https://pubmed.ncbi.nlm.nih.gov/41901344/). *Pharmaceuticals (Basel)*. [Basic Science / Preclinical]
Kondo K (2026). [PMID: 41711876](https://pubmed.ncbi.nlm.nih.gov/41711876/). *J Bone Miner Metab*. [Review / Meta-Analysis]
Lin S (2026). [PMID: 41141582](https://pubmed.ncbi.nlm.nih.gov/41141582/). *Bioact Mater*. [Gene Therapy / Novel Therapeutics]
Jiang Y (2026). [PMID: 42095873](https://pubmed.ncbi.nlm.nih.gov/42095873/). *Mol Genet Genomics*. [Basic Science / Preclinical]
Santos I (2026). [PMID: 41352702](https://pubmed.ncbi.nlm.nih.gov/41352702/). *Eur J Pharmacol*. [Basic Science / Preclinical]
Hu L (2026). [PMID: 42147718](https://pubmed.ncbi.nlm.nih.gov/42147718/). *Cancer Drug Resist*. [Basic Science / Preclinical]
Bassi G (2026). [PMID: 41496360](https://pubmed.ncbi.nlm.nih.gov/41496360/). *Biomed Pharmacother*. [Basic Science / Preclinical]
Lee J (2026). [PMID: 41362255](https://pubmed.ncbi.nlm.nih.gov/41362255/). *Lab Chip*. [Diagnostic / Biomarker]
Saoud C (2026). [PMID: 41203137](https://pubmed.ncbi.nlm.nih.gov/41203137/). *Mod Pathol*. [Case Report / Case Series]
Rossi M (2026). [PMID: 42134242](https://pubmed.ncbi.nlm.nih.gov/42134242/). *Biomed Pharmacother*. [Basic Science / Preclinical]